Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pharmadrug Inc (PHRX.CN)

Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,624
  • Shares Outstanding, K 108,234
  • Annual Sales, $ 0 K
  • Annual Income, $ -793 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.54
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on 11/24/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0150 unch
on 12/19/25
0.0200 -25.00%
on 12/12/25
-0.0050 (-25.00%)
since 11/19/25
3-Month
0.0100 +50.00%
on 10/29/25
0.0250 -40.00%
on 11/05/25
+0.0050 (+50.00%)
since 09/19/25
52-Week
0.0050 +200.00%
on 09/15/25
0.0250 -40.00%
on 11/05/25
+0.0050 (+50.00%)
since 12/19/24

Most Recent Stories

More News
PharmaDrug Announces Debt Restructuring

Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc

Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Inc.: Correction to News Release Dated July 30, 2025

Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), announces that the original news release captioned "PharmaDrug Signs...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Signs LOI to Acquire Equity Interest in Canurta Inc.

Toronto, Ontario--(Newsfile Corp. - July 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Announces Resignation of Rob Steen as CEO and From Board of Directors

Toronto, Ontario--(Newsfile Corp. - June 16, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value

Toronto, Ontario--(Newsfile Corp. - June 6, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Announces Issuance of Debenture Units

Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug Announces Proposed Issuance of Debenture Units

Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases

Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)
PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases

Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (unch)
LMLLF : 0.0124 (-11.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically,...

See More

Key Turning Points

3rd Resistance Point 0.0150
2nd Resistance Point 0.0150
1st Resistance Point 0.0150
Last Price 0.0150
1st Support Level 0.0150
2nd Support Level 0.0150
3rd Support Level 0.0150

See More

52-Week High 0.0250
Fibonacci 61.8% 0.0174
Fibonacci 50% 0.0150
Last Price 0.0150
Fibonacci 38.2% 0.0126
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar